SUNLINDAC
- Product NDC
- 61919-211
- 11-digit product format
- 619190211
- Labeler code
- 61919
- Product ID
- 61919-211_9cad4d33-4565-89e0-e053-2a95a90a0cb2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SULINDAC
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct Rx
- Application
- ANDA072051
- Marketing category
- ANDA
- Marketing start
- 2014-01-01
- Marketing end
- 0000-00-00
- Substance
- SULINDAC
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-211-30 | 61919021130 | 30 TABLET in 1 BOTTLE (61919-211-30) | 30 tablet | 2014-04-02 | 0000-00-00 | No | No | Current |